Coat as a dagger: The use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking

Viruses

Volumn 6, Issue 7, 2014, Pages 2899-2937

  Bilkova, Eva ^a   Forstova, Jitka ^a   Abrahamyan, Levon ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adenovirus; Capsid protein; Cell entry; Coat protein; Endosome escape; Membrane perforation; Papillomavirus; Parvovirus; Polyomavirus; Trafficking; Viroporins; Viruses

Indexed keywords

CAPSID PROTEIN; PHOSPHOLIPASE A2; PROTEIN VI; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; SERINE PROTEINASE INHIBITOR; SORTING NEXIN 17; UNCLASSIFIED DRUG; PROTEIN BINDING; VIRUS RECEPTOR;

ADENOVIRUS; CELL MIGRATION; DNA VIRUS; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOSOME; ESCAPE BEHAVIOR; HUMAN; INTRACELLULAR MEMBRANE; MEMBRANE TRANSPORT; MOLECULAR GENETICS; NON ENVELOPED DNA VIRUS; NONHUMAN; NUCLEAR TRANSLOCATION; PAPILLOMA VIRUS; PARVOVIRUS; POLYOMA VIRUS; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; VIRAL PHENOMENA AND FUNCTIONS; VIRUS ENTRY; VIRUS TRAFFICKING; ADENOVIRIDAE; CELL MEMBRANE; CELL NUCLEUS; CHEMISTRY; EUKARYOTIC CELL; HOST PATHOGEN INTERACTION; METABOLISM; PARVOVIRIDAE; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY; VIRUS REPLICATION;

ADENOVIRIDAE; CAPSID PROTEINS; CELL MEMBRANE; CELL NUCLEUS; ENDOSOMES; EUKARYOTIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; PAPILLOMAVIRIDAE; PARVOVIRIDAE; POLYOMAVIRIDAE; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, VIRUS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84904977774     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6072899     Document Type: Review

References (235)

1. Day, P.M.; Schelhaas, M. Concepts of papillomavirus entry into host cells. Curr. Opin. Virol. 2014, 4, 24-31.
2. Cerqueira, C.; Schelhaas, M. Principlesof polyoma-and papillomavirus uncoating. Med. Microbiol. Immunol. 2012, 201, 427-436.
3. Puntener, D.; Greber, U.F. Dna-tumor virus entry-from plasma membrane to the nucleus. Semin. Cell Dev. Biol. 2009, 20, 631-642.
4. Benevento, M.; Di Palma, S.; Snijder, J.; Moyer, C.L.; Reddy, V.S.; Nemerow, G.R.; Heck, A.J. Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics. J. Biol. Chem. 2014, 289, 11421-11430.
5. Wickham, T.J.; Mathias, P.; Cheresh, D.A.; Nemerow, G.R. Integrin-alpha-v-beta-3 and integrinalpha-v-beta-5 promote adenovirus internalization but not virus attachment. Cell 1993, 73, 309-319.
6. Mathias, P.; Wickham, T.; Moore, M.; Nemerow, G. Multiple adenovirus serotypes use alpha-v integrins for infection. J. Virol. 1994, 68, 6811-6814.
7. Huang, S.A.; Endo, R.I.; Nemerow, G.R. Up-regulation of integrins alpha-v-beta-3 and alpha-vbeta-5 on human monocytes and t-lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 1995, 69, 2257-2263.
8. Davison, E.; Diaz, R.M.; Hart, I.R.; Santis, G.; Marshall, J.F. Integrin alpha 5 beta 1-mediated adenovirus infection is enhanced by the integrin-activating antibody ts2/16. J. Virol. 1997, 71, 6204-6207.
9. Nemerow, G.R.; Stewart, P.L. Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol. Mol. Biol. Rev. 1999, 63, 725-734.
10. Wang, K.N.; Huang, S.; Kapoor-Munshi, A.; Nemerow, G. Adenovirus internalization and infection require dynamin. J. Virol. 1998, 72, 3455-3458.
11. Amstutz, B.; Gastaldelli, M.; Kalin, S.; Imelli, N.; Boucke, K.; Wandeler, E.; Mercer, J.; Hemmi, S.; Greber, U.F. Subversion of ctbp1-controlled macropinocytosisby human adenovirus serotype 3. EMBO J. 2008, 27, 956-969.
12. Imelli, N.; Ruzsics, Z.; Puntener, D.; Gastaldelli, M.; Greber, U.F. Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol. J. 2009, 6, 174.
13. Meier, O.; Boucke, K.; Hammer, S.V.; Keller, S.; Stidwill, R.P.; Hemmi, S.; Greber, U.F. Adenovirus triggers macropinocytosis and endosomalleakage together withits clathrin-mediated uptake. J. Cell Biol. 2002, 158, 1119-1131.
14. Kaelin, S.; Amstutz, B.; Gastaldelli, M.; Wolfrum, N.; Boucke, K.; Havenga, M.; DiGennaro, F.; Liska, N.; Hemmi, S.; Greber, U.F. Macropinocytotic uptake and infection of human epithelial cells with species b2 adenovirus type 35. J. Virol. 2010, 84, 5336-5350.
15. Burckhardt, C.J.; Suomalainen, M.; Schoenenberger, P.; Boucke, K.; Hemmi, S.; Greber, U.F. Drifting motions of the adenovirus receptor car and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 2011, 10, 105-117.
16. Nakano, M.Y.; Boucke, K.; Suomalainen, M.; Stidwill, R.P.; Greber, U.F. The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J. Virol. 2000, 74, 7085-7095.
17. Shayakhmetov, D.M.; Li, Z.Y.; Gaggar, A.; Gharwan, H.; Ternovoi, V.; Sandig, V.; Lieber, A. Genome size and structure determine efficiency ofpostinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner. J. Virol. 2004, 78, 10009-10022.
18. Shayakhmetov, D.M.; Eberly, A.M.; Li, Z.Y.; Lieber, A. Deletion of penton rgd motifs affects the efficiency of both the internalization and the endosorne escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J. Virol. 2005, 79, 1053-1061.
19. Miyazawa, N.; Crystal, R.G.; Leopold, P.L. Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J. Virol. 2001, 75, 1387-1400.
20. Miyazawa, N.; Leopold, P.L.; Hackett, N.R.; Ferris, B.; Worgall, S.; Falck-Pedersen, E.; Crystal, R.G. Fiber swap between adenovirus subgroups b and c alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 1999, 73, 6056-6065.
21. Martin-Fernandez, M.; Longshaw, S.V.; Kirby, I.; Santis, G.; Tobin, M.J.; Clarke, D.T.; Jones, G.R. Adenovirus type-5 entry and disassemblyfollowed in living cells by fret, fluorescence anisotropy, and flim. Biophys. J. 2004, 87, 1316-1327.
22. Greber, U.F.; Willetts, M.; Webster, P.; Helenius, A. Stepwise dismantling of adenovirus-2 during entry into cells. Cell 1993, 75, 477-486.
23. Carey, B.; Staudt, M.K.; Bonaminio, D.; van der Loo, J.C.M.; Trapnell, B.C. Pu.1 redirects adenovirus to lysosomes in alveolar macrophages, uncoupling internalization from infection. J. Immunol. 2007, 178, 2440-2447.
24. Engesaeter, B.O.; Tveito, S.; Bonsted, A.; Engebraaten, O.; Berg, K.; Maelandsmo, G.M. Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus. J. Gene Med. 2006, 8, 707-718.
25. Maier, O.; Marvin, S.A.; Wodrich, H.; Campbell, E.M.; Wiethoff, C.M. Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J. Virol. 2012, 86, 10821-10828.
26. Gastaldelli, M.; Imelli, N.; Boucke, K.; Amstutz, B.; Meier, O.; Greber, U.F. Infectious adenovirus type 2 transport through early but not late endosomes. Traffic 2008, 9, 2265-2278.
27. Morgan, C.; Rosenkra, H.S.; Mednis, B. Structure and development of viruses as observed in electron microscope. 10. Entry and uncoating of adenovirus. J. Virol. 1969, 4, 777-796.
28. Seth, P. Adenovirus-dependent release of choline from plasma-membrane vesicles at an acidic ph is mediated by the penton base protein. J. Virol. 1994, 68, 1204-1206.
29. Prchla, E.; Plank, C.; Wagner, E.; Blaas, D.; Fuchs, R. Virus-mediated release of endosomal content in-vitro-Different behavior of adenovirus and rhinovirus serotype-2. J. Cell Biol. 1995, 131, 111-123.
30. Suomalainen, M.; Luisoni, S.; Boucke, K.; Bianchi, S.; Engel, D.A.; Greber, U.F. A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J. Virol. 2013, 87, 12367-12379.
31. Farr, G.A.; Zhang, L.G.; Tattersall, P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. USA 2005, 102, 17148-17153.
32. Kato, S.E.; Chahal, J.S.; Flint, S.J. Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incompleteprocessing of the preterminal protein. J. Virol. 2012, 86, 13554-13565.
33. Wiethoff, C.M.; Wodrich, H.; Gerace, L.; Nemerow, G.R. Adenovirus protein vi mediates membrane disruption following capsid disassembly. J. Virol. 2005, 79, 1992-2000.
34. Greber, U.F.; Webster, P.; Weber, J.; Helenius, A. The role of the adenovirus protease in virus entry into cells. EMBO J. 1996, 15, 1766-1777.
35. Wodrich, H.; Guan, T.L.; Cingolani, G.; Von Seggern, D.; Nemerow, G.; Gerace, L. Switch from capsid protein import to adenovirus assembly by cleavage of nucleartransport signals. EMBO J. 2003, 22, 6245-6255.
36. Van Oostrum, J.; Burnett, R.M. The structure of the adenovirus capsid. Biophys. J. 1985, 47, 394A-394A.
37. Lehmberg, E.; Traina, J.A.; Chakel, J.A.; Chang, R.J.; Parkman, M.; McCaman, M.T.; Murakami, P.K.; Lahidji, V.; Nelson, J.W.; Hancock, W.S.; et al. Reversed-phase highperformance liquid chromatographic assay for the adenovirus type 5 proteome. J. Chrom. B Biomed. Sci. Appl. 1999, 732, 411-423.
38. Saban, S.D.; Nepomuceno, R.R.; Gritton, L.D.; Nemerow, G.R.; Stewart, P.L. Cryoem structure at 9 angstrom resolution of an adenovirus vector targeted to hematopoietic cells. J. Mol. Biol. 2005, 349, 526-537.
39. Silvestry, M.; Lindert, S.; Smith, J.G.; Maier, O.; Wiethoff, C.M.; Nemerow, G.R.; Stewart, P.L. Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J. Virol. 2009, 83, 7375-7383.
40. Liu, H.R.; Jin, L.; Koh, S.B.S.; Atanasov, I.; Schein, S.; Wu, L.; Zhou, Z.H. Atomic structure of human adenovirus by cryo-em reveals interactions among protein networks. Science 2010, 329, 1038-1043.
41. Mangel, W.F.; McGrath, W.J.; Toledo, D.L.; Anderson, C.W. Viral-dna and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature 1993, 361, 274-275.
42. Wodrich, H.; Henaff, D.; Jammart, B.; Segura-Morales, C.; Seelmeir, S.; Coux, O.; Ruzsics, Z.; Wiethoff, C.M.; Kremer, E.J. A capsid-encoded ppxy-motif facilitates adenovirus entry. PLoS Pathog. 2010, 6, e1000808.
43. Moyer, C.L.; Wiethoff, C.M.; Maier, O.; Smith, J.G.; Nemerow, G.R. Functional genetic and biophysical analyses of membranedisruption by human adenovirus. J. Virol. 2011, 85, 2631-2641.
44. Moyer, C.L.; Nemerow, G.R. Disulfide-bond formation by a single cysteine mutation in adenovirus protein vi impairs capsid release and membrane lysis. Virology 2012, 428, 41-47.
45. Maier, O.; Galan, D.L.; Wodrich, H.; Wiethoff, C.M. An n-terminal domain of adenovirus protein vi fragments membranes by inducing positive membrane curvature. Virology 2010, 402, 11-19.
46. Ganz, T. Defensins: Antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 2003, 3, 710-720.
47. Nguyen, E.K.; Nemerow, G.R.; Smith, J.G. Direct evidence from single-cell analysis that human alpha-defensins block adenovirus uncoating to neutralize infection. J. Virol. 2010, 84, 4041-4049.
48. Smith, J.G.; Silvestry, M.; Lindert, S.; Lu, W.Y.; Nemerow, G.R.; Stewart, P.L. Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog. 2010, 6, e1000959
49. Flatt, J.W.; Kim, R.; Smith, J.G.; Nemerow, G.R.; Stewart, P.L. An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One 2013, 8, e61571.
50. Snijder, J.; Reddy, V.S.; May, E.R.; Roos, W.H.; Nemerow, G.R.; Wuite, G.J.L. Integrin and defensin modulate the mechanical properties of adenovirus. J. Virol. 2013, 87, 2756-2766.
51. Bremner, K.H.; Scherer, J.; Yi, J.L.; Vershinin, M.; Gross, S.P.; Vallee, R.B. Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 2009, 6, 523-535.
52. Suomalainen, M.; Nakano, M.Y.; Boucke, K.; Keller, S.; Greber, U.F. Adenovirus-activated pka and p38/mapk pathways boost microtubule-mediated nuclear targeting of virus. EMBO J. 2001, 20, 1310-1319.
53. Saphire, A.C.S.; Guan, T.L.; Schirmer, E.C.; Nemerow, G.R.; Gerace, L. Nuclear import adenovirus dna in vitro involves the nuclear protein import pathway and hsc70. J. Biol. Chem. 2000, 275, 4298-4304.
54. Trotman, L.C.; Mosberger, N.; Fornerod, M.; Stidwill, R.P.; Greber, U.F. Import of adenovirus dna involves the nuclear pore complex receptor can/nup214 and histone h1. Nat. Cell Biol. 2001, 3, 1092-1100.
55. Hindley, C.E.; Lawrence, F.J.; Matthews, D.A. A role for transportin in the nuclear import of adenovirus core proteins and dna. Traffic 2007, 8, 1313-1322.
56. Strunze, S.; Trotman, L.C.; Boucke, K.; Greber, U.F. Nuclear targeting of adenovirus type 2 requires crm1-mediated nuclear export. Mol. Biol. Cell 2005, 16, 2999-3009.
57. Ozawa, K.; Young, N. Characterization of capsid and noncapsid proteins of b19 parvovirus propagated in human erythroid bone-marrow cell-cultures. J. Virol. 1987, 61, 2627-2630.
58. Tattersall, P.; Cawte, P.J.; Shatkin, A.J.; Ward, D.C. 3 structural polypeptides coded for by minute virus of mice, a parvovirus. J. Virol. 1976, 20, 273-289.
59. Cotmore, S.F.; Tattersall, P. The autonomously replicating parvoviruses of vertebrates. Adv. Virus Res. 1987, 33, 91-174.
60. Paradiso, P.R.; Rhode, S.L.; Singer, II. Canineparvovirus-A biochemical and ultrastructural characterization. J. Gen. Virol. 1982, 62, 113-125.
61. Rose, J.A.; Maizel, J.V.; Inman, J.K.; Shatkin, A.J. Structural proteins ofadenovirus-associated viruses. J. Virol. 1971, 8, 766-770.
62. Bartlett, J.S.; Wilcher, R.; Samulski, R.J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 2000, 74, 2777-2785.
63. Summerford, C.; Samulski, R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 1998, 72, 1438-1445.
64. Parker, J.S.L.; Murphy, W.J.; Wang, D.; O'Brien, S.J.; Parrish, C.R. Canine and feline parvoviruses can use human or feline transferrin receptors to bind, enter, and infect cells. J. Virol. 2001, 75, 3896-3902.
65. Hueffer, K.; Parker, J.S.L.; Weichert, W.S.; Geisel, R.E.; Sgro, J.Y.; Parrish, C.R. The natural host range shift and subsequent evolution of canine parvovirus resulted from virus-specific binding to the canine transferrin receptor. J. Virol. 2003, 77, 1718-1726.
66. Johnson, F.B.; Fenn, L.B.; Owens, T.J.; Faucheux, L.J.; Blackburn, S.D. Attachment of bovine parvovirus to sialic acids on bovine cell membranes. J. Gen. Virol. 2004, 85, 2199-2207.
67. Brown, K.E.; Anderson, S.M.; Young, N.S. Erythrocyte-p antigen-Cellular receptor for b19 parvovirus. Science 1993, 262, 114-117.
68. Munakata, Y.; Saito-Ito, T.; Kumura-Ishii, K.; Huang, J.; Kodera, T.; Ishii, T.; Hirabayashi, Y.; Koyanagi, Y.; Sasaki, T. Ku80 autoantigen as a cellular coreceptor for human parvovirus b19 infection. Blood 2005, 106, 3449-3456.
69. Weigel-Kelley, K.A.; Yoder, M.C.; Srivastava, A. Alpha 5 beta 1 integrin as a cellular coreceptor for human parvovirus b19: Requirement of functional activation of beta 1 integrin for viral entry. Blood 2003, 102, 3927-3933.
70. Duan, D.S.; Li, Q.; Kao, A.W.; Yue, Y.P.; Pessin, J.E.; Engelhardt, J.F. Dynamin is required for recombinant adeno-associatedvirus type 2 infection. J. Virol. 1999, 73, 10371-10376.
71. Parker, J.S.L.; Parrish, C.R. Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking. J. Virol. 2000, 74, 1919-1930.
72. Bantel-Schaal, U.; Hub, B.; Kartenbeck, J. Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the golgi compartment. J. Virol. 2002, 76, 2340-2349.
73. Dudleenamjil, E.; Lin, C.-Y.; Dredge, D.; Murray, B.K.; Robison, R.A.; Johnson, F.B. Bovine parvovirus uses clathrin-mediated endocytosis for cell entry. J. Gen. Virol. 2010, 91, 3032-3041.
74. Bantel-Schaal, U.; Braspenning-Wesch, I.; Kartenbeck, J. Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts. J. Gen. Virol. 2009, 90, 317-322.
75. Boisvert, M.; Fernandes, S.; Tijssen, P. Multiple pathways involved in porcine parvovirus cellular entry and trafficking toward the nucleus. J. Virol. 2010, 84, 7782-7792.
76. Suikkanen, S.; Saarjarvi, K.; Hirsimaki, J.; Valilehto, O.; Reunanen, H.; Vihinen-Ranta, M.; Vuento, M. Role of recycling endosomes and lysosomes in dynein-dependent entry of canine parvovirus. J. Virol. 2002, 76, 4401-4411.
77. VihinenRanta, M.; Kalela, A.; Makinen, P.; Kakkola, L.; Marjomaki, V.; Vuento, M. Intracellular route of canine parvovirus entry. J. Virol. 1998, 72, 802-806.
78. Vihinen-Ranta, M.; Yuan, W.; Parrish, C.R. Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport. J. Virol. 2000, 74, 4853-4859.
79. Vendeville, A.; Ravallec, M.; Jousset, F.X.; Devise, M.; Mutuel, D.; Lopez-Ferber, M.; Fournier, P.; Dupressoir, T.; Ogliastro, M. Densovirus infectious pathway requires clathrin-mediated endocytosis followed by trafficking to the nucleus. J. Virol. 2009, 83, 4678-4689.
80. Sanlioglu, S.; Benson, P.K.; Yang, J.S.; Atkinson, E.M.; Reynolds, T.; Engelhardt, J.F. Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 2000, 74, 9184-9196.
81. Pakkanen, K.; Karttunen, J.; Virtanen, S.; Vuento, M. Sphingomyelin induces structural alteration in canine parvovirus capsid. Virus Res. 2008, 132, 187-191.
82. Mani, B.; Baltzer, C.; Valle, N.; Almendral, J.M.; Kempf, C.; Ros, C. Low ph-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the vp1n-terminal sequence (n-vp1), n-vp2 cleavage, and uncoating of the fulllength genome. J. Virol. 2006, 80, 1015-1024.
83. Ros, C.; Baltzer, C.; Mani, B.; Kempf, C. Parvovirus uncoating in vitro reveals a mechanism of dna release without capsid disassembly and striking differences in encapsidated dna stability. Virology 2006, 345, 137-147.
84. Suikkanen, S.; Antila, M.; Jaatinen, A.; Vihinen-Ranta, M.; Vuento, M. Release of canine parvovirus from endocytic vesicles. Virology 2003, 316, 267-280.
85. Sonntag, F.; Bleker, S.; Leuchs, B.; Fischer, R.; Kleinschmidt, J.A. Adeno-associated virus type 2 capsids with externalized vp1/vp2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 2006, 80, 11040-11054.
86. Farr, G.A.; Cotmore, S.F.; Tattersall, P. Vp2 cleavage and the leucine ring at the base of the fivefold cylinder control ph-dpendent externalization of both the vp1 n terminus and the genome of minute virus of mice. J. Virol. 2006, 80, 161-171.
87. Weichert, W.S.; Parker, J.S.L.; Wahid, A.T.M.; Chang, S.F.; Meier, E.; Parrish, C.R. Assaying for structural variation in the parvovirus capsid and its role in infection. Virology 1998, 250, 106-117.
88. Cotmore, S.F.; Hafenstein, S.; Tattersall, P. Depletion of virion-associated divalent cations induces parvovirus minute virus of mice to eject its genome in a 3'-to-5' direction from an otherwise intact viral particle. J. Virol. 2010, 84, 1945-1956.
89. Vihinen-Ranta, M.; Yuan, W.; Weichert, W.; Vuento, M.; Parrish, C.R. The vp1n-terminal sequence of canine parvovirus is important for efficient cell infection. Mol. Biol. Cell 2000, 11, 291A-291A.
90. Vihinen-Ranta, M.; Wang, D.; Weichert, W.S.; Parrish, C.R. The vp1n-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection. J. Virol. 2002, 76, 1884-1891.
91. Farr, G.A.; Tattersall, P. A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central rolein parvoviral infection. Virology 2004, 323, 243-256.
92. Cotmore, S.F.; D'Abramo, A.M.; Ticknor, C.M.; Tattersall, P. Controlled conformational transitions in the mvm virion expose the vp1 n-terminus and viral genome without particle disassembly. Virology 1999, 254, 169-181.
93. Akache, B.; Grimm, D.; Shen, X.; Fuess, S.; Yant, S.R.; Glazer, D.S.; Park, J.; Kay, M.A. A twohybrid screen identifies cathepsins b and l as uncoating factors for adeno-associated virus 2 and 8. Mol. Ther. 2007, 15, 330-339.
94. Dorsch, S.; Liebisch, G.; Kaufmann, B.; von Landenberg, P.; Hoffmann, J.H.; Drobnik, W.; Modrow, S. The vp1 unique region of parvovirus b19 and its constituent phospholipase a2-like activity. J. Virol. 2002, 76, 2014-2018.
95. Girod, A.; Wobus, C.E.; Zadori, Z.; Ried, M.; Leike, K.; Tijssen, P.; Kleinschmidt, J.A.; Hallek, M. The vp1 capsid protein of adeno-associatedvirus type 2 is carrying a phospholipase a2 domain required for virus infectivity. J. Gen. Virol. 2002, 83, 973-978.
96. VihinenRanta, M.; Kakkola, L.; Kalela, A.; Vilja, P.; Vuento, M. Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur. J. Biochem. 1997, 250, 389-394.
97. Zadori, Z.; Szelei, J.; Lacoste, M.C.; Li, Y.; Gariepy, S.; Raymond, P.; Allaire, M.; Nabi, I.R.; Tijssen, P. A viral phospholipase a(2) is required for parvovirus infectivity. Dev. Cell 2001, 1, 291-302.
98. Canaan, S.; Zadori, Z.; Ghomashchi, F.; Bollinger, J.; Sadilek, M.; Moreau, M.E.; Tijssen, P.; Gelb, M.H. Interfacial enzymology of parvovirus phospholipases a(2). J. Biol. Chem. 2004, 279, 14502-14508.
99. Lu, J.; Zhi, N.; Wong, S.; Brown, K.E. Activation of synoviocytes by the secreted phospholipase a(2) motif in the vp1-unique region of parvovirus b19 minor capsid protein. J. Infect. Dis. 2006, 193, 582-590.
100. Murakami, M.; Kudo, I. Recent advances inmolecular biology and physiology of the prostaglandin e-2-biosynthetic pathway. Prog. Lipid Res. 2004, 43, 3-35.
101. Martel-Pelletier, J.; Pelletier, J.P.; Fahmi, H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin. Arthritis Rheum. 2003, 33, 155-167.
102. Stahnke, S.; Lux, K.; Uhrig, S.; Kreppel, F.; Hosel, M.; Coutelle, O.; Ogris, M.; Hallek, M.; Buning, H. Intrinsic phospholipase a2 activity ofadeno-associated virus is involved in endosomal escape of incoming particles. Virology 2011, 409, 77-83.
103. Filippone, C.; Zhi, N.; Wong, S.; Lu, J.; Kajigaya, S.; Gallinella, G.; Kakkola, L.; SoderlundVenenno, M.; Young, N.S.; Brown, K.E. Vp1u phospholipase activity is critical for infectivity of full-length parvovirus b19 genomic clones. Virology 2008, 374, 444-452.
104. Deng, X.F.; Dong, Y.M.; Yi, Q.H.; Huang, Y.; Zhao, D.; Yang, Y.B.; Tijssen, P.; Qiu, J.M.; Liu, K.Y.; Li, Y. The determinants for the enzyme activity of human parvovirus b19 phospholipase a2 (pla2) and its influence on cultured cells. PLoS One 2013, 8, e61440.
105. Pakkanen, K.; Kirjavainen, S.; Makela, A.R.; Rintanen, N.; Oker-Blom, C.; Jalonen, T.O.; Vuento, M. Parvovirus capsid disorders cholesterol-rich membranes. Biochem. Biophys. Res. Comm. 2009, 379, 562-566.
106. Bonsch, C.; Kempf, C.; Ros, C. Interaction ofparvovirus b19 with humanerythrocytes alters virus structure and cell membrane integrity. J. Virol. 2008, 82, 11784-11791.
107. Lupescu, A.; Bock, C.T.; Lang, P.A.; Aberle, S.; Kaiser, H.; Kandolf, R.; Lang, F. Phospholipase a2 activity-dependent stimulation of ca2+ entry by human parvovirus b19 capsid protein vp1. J. Virol. 2006, 80, 11370-11380.
108. Almilaji, A.; Szteyn, K.; Fein, E.; Pakladok, T.; Munoz, C.; Elvira, B.; Towhid, S.T.; Alesutan, I.; Shumilina, E.; Bock, C.T.;et al. Down-regulation of na+/k+ atpase activity by human parvovirus b19 capsid protein vp1. Cell. Physiol. Biochem. 2013, 31, 638-648.
109. Venkatakrishnan, B.; Yarbrough, J.; Domsic, J.; Bennett, A.; Bothner, B.; Kozyreva, O.G.; Samulski, R.J.; Muzyczka, N.; McKenna, R.; Agbandje-McKenna, M. Structure and dynamics of adeno-associated virus serotype 1 vp1-unique n-terminal domain and its role in capsid trafficking. J. Virol. 2013, 87, 4974-4984.
110. Lux, K.; Goerlitz, N.; Schlemminger, S.; Perabo, L.; Goldnau, D.; Endell, J.; Leike, K.; Kofler, D.M.; Finke, S.; Hallek, M.; et al. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking. J. Virol. 2005, 79, 11776-11787.
111. Cohen, S.; Behzad, A.R.; Carroll, J.B.; Pante, N. Parvoviral nuclear import: Bypassing the host nuclear-transport machinery. J. Gen. Virol. 2006, 87, 3209-3213.
112. Cohen, S.; Marr, A.K.; Garcin, P.; Pante, N. Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle. J. Virol. 2011, 85, 4863-4874.
113. Hansen, J.; Qing, K.; Srivastava, A. Infection ofpurified nuclei by adeno-associated virus 2. Mol. Ther. 2001, 4, 289-296.
114. Nicolson, S.C.; Samulski, R.J. Adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus. Mol. Ther. 2013, 21, S30-S30.
115. Baker, T.S.; Newcomb, W.W.; Olson, N.H.; Cowsert, L.M.; Olson, C.; Brown, J.C. Structures of bovine and human papillomaviruses-Analysis by cryoelectron microscopy and 3-dimensional image-reconstruction. Biophys. J. 1991, 60, 1445-1456.
116. Giroglou, T.; Florin, L.; Schafer, F.; Streeck, R.E.; Sapp, M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 2001, 75, 1565-1570.
117. Joyce, J.G.; Tung, J.S.; Przysiecki, C.T.; Cook, J.C.; Lehman, E.D.; Sands, J.A.; Jansens, K.U.; Keller, P.M. The l1 major capsid protein of human papillomavirus type 11 recombinant viruslike particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 1999, 274, 5810-5822.
118. Gambhira, R.; Karanam, B.; Jagu, S.; Roberts, J.N.; Buck, C.B.; Bossis, I.; Alphs, H.; Culp, T.; Christensen, N.D.; Roden, R.B.S. A protective and broadly cross-neutralizing epitope of human papillomavirus l2. J. Virol. 2007, 81, 13927-13931.
119. Richards, R.M.; Lowy, D.R.; Schiller, J.T.; Day, P.M. Cleavage of the papillomavirus minor capsid protein, l2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. USA 2006, 103, 1522-1527.
120. Chen, X.; Liu, H.; Zhang, T.; Liu, Y.; Xie, X.; Wang, Z.; Xu, X. A vaccine of l2 epitope repeats fused with a modified igg1 fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types. PLoS One 2014, 9, e95448.
121. Bienkowska-Haba, M.; Patel, H.D.; Sapp, M. Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog. 2009, 5, e1000524.
122. Kines, R.C.; Thompson, C.D.; Lowy, D.R.; Schiller, J.T.; Day, P.M. The initial steps leading to papillomavirus infection occur on the basementmembrane prior to cell surface binding. Proc. Natl. Acad. Sci. USA 2009, 106, 20458-20463.
123. Horvath, C.A.J.; Boulet, G.A.V.; Renoux, V.M.; Delvenne, P.O.; Bogers, J.P.J. Mechanisms of cell entry by human papillomaviruses: An overview. Virol. J. 2010, 7, 11.
124. Laniosz, V.; Holthusen, K.A.; Meneses, P.I. Bovine papillomavirus type 1: From clathrin to caveolin. J. Virol. 2008, 82, 6288-6298.
125. Smith, J.L.; Campos, S.K.; Ozbun, M.A. Human papillomavirus type 31 uses a caveolin 1-and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 2007, 81, 9922-9931.
126. Bousarghin, L.; Touze, A.; Sizaret, P.Y.; Coursaget, P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 2003, 77, 3846-3850.
127. Day, P.M.; Lowy, D.R.; Schiller, J.T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307, 1-11.
128. Spoden, G.; Freitag, K.; Husmann, M.; Boller, K.; Sapp, M.; Lambert, C.; Florin, L. Clathrin-and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspaninenriched microdomains (tems). PLoS One 2008, 3, e3313.
129. Schelhaas, M.; Shah, B.; Holzer, M.; Blattmann, P.; Kuhling, L.; Day, P.M.; Schiller, J.T.; Helenius, A. Entry of human papillomavirus type 16 by actin-dependent, clathrin-and lipid raftindependent endocytosis. PLoS Pathog. 2012, 8, e1002657.
130. Spoden, G.; Kuhling, L.; Cordes, N.; Frenzel, B.; Sapp, M.; Boller, K.; Florin, L.; Schelhaas, M. Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J. Virol. 2013, 87, 7765-7773.
131. Lipovsky, A.; Popa, A.; Pimienta, G.; Wyler, M.; Bhan, A.; Kuruvilla, L.; Guie, M.A.; Poffenberger, A.C.; Nelson, C.D.S.; Atwood, W.J.; et al. Genome-wide sirna screen identifies the retromer as a cellular entry factor for human papillomavirus. Proc. Natl. Acad. Sci. USA 2013, 110, 7452-7457.
132. Bossis, L.; Roden, R.B.S.; Gambhira, R.; Yang, R.; Tagaya, M.; Howley, P.A.; Meneses, P.I. Interaction of tsnare syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J. Virol. 2005, 79, 6723-6731.
133. Laniosz, V.; Dabydeen, S.A.; Havens, M.A.; Meneses, P.I. Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J. Virol. 2009, 83, 8221-8232.
134. Karanam, B.; Peng, S.W.; Li, T.; Buck, C.; Day, P.M.; Roden, R.B.S. Papillomavirus infection requires gamma secretase. J. Virol. 2010, 84, 10661-10670.
135. Campos, S.K.; Chapman, J.A.; Deymier, M.J.; Bronnimann, M.P.; Ozbun, M.A. Opposing effects of bacitracin on human papillomavirus type 16 infection: Enhancement of binding and entry and inhibition of endosomal penetration. J. Virol. 2012, 86, 4169-4181.
136. Selinka, H.C.; Giroglou, T.; Sapp, M. Analysisof the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 2002, 299, 279-287.
137. Dabydeen, S.A.; Meneses, P.I. The role ofnh(4)cl and cysteineproteases in human papillomavirus type 16 infection. Virol. J. 2009, 6, 109.
138. Muller, K.H.; Spoden, G.A.; Scheffer, K.D.; Brunnhofer, R.; De Brabander, J.K.; Maier, M.E.; Florin, L.; Muller, C.P. Inhibition by cellular vacuolar atpase impairs human papillomavirus uncoating and infection. Antimicrob. Agents Chemother. 2014, 58, 2905-2911.
139. Selinka, H.C.; Giroglou, T.; Nowak, T.; Christensen, N.D.; Sapp, M. Further evidence that papillomavirus capsids exist intwo distinct conformations. J. Virol. 2003, 77, 12961-12967.
140. Finnen, R.L.; Erickson, K.D.; Chen, X.J.S.; Garcea, R.L. Interactions between papillomavirus l1 and l2 capsid proteins. J. Virol. 2003, 77, 4818-4826.
141. Buck, C.B.; Cheng, N.; Thompson, C.D.; Lowy, D.R.; Steven, A.C.; Schiller, J.T.; Trus, B.L. Arrangement of l2 within the papillomavirus capsid. J. Virol. 2008, 82, 5190-5197.
142. Trus, B.L.; Roden, R.B.S.; Greenstone, H.L.; Vrhel, M.; Schiller, J.T.; Booy, F.P. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 angstrom resolution. Nat. Struct. Biol. 1997, 4, 413-420.
143. Liu, W.J.; Gissmann, L.; Sun, X.Y.; Kanjanahaluethai, A.; Muller, M.; Doorbar, J.; Zhou, J. Sequence close to the n-terminus of l2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 1997, 227, 474-483.
144. Kondo, K.; Ishii, Y.; Ochi, H.; Matsumoto, T.; Yoshikawa, H.; Kanda, T. Neutralization of hpv16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the hpv 16 minor capsid protein l2 surface region. Virology 2007, 358, 266-272.
145. Mamoor, S.; Onder, Z.; Karanam, B.; Kwak, K.; Bordeaux, J.; Crosby, L.; Roden, R.B.S.; Moroianu, J. The high risk hpv16 l2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology 2012, 422, 413-424.
146. Darshan, M.S.; Lucchi, J.; Harding, E.; Moroianu, J. The l2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J. Virol. 2004, 78, 12179-12188.
147. Fay, A.; Yutzy, W.H.; Roden, R.B.S.; Moroianu, J. The positively charged termini of l2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and dna binding. J. Virol. 2004, 78, 13447-13454.
148. Zhou, J.; Sun, X.Y.; Louis, K.; Frazer, I.H. Interaction of human papillomavirus (hpv) type-16 capsid proteins with hpv dna requires an intact l2 n-terminal sequence. J. Virol. 1994, 68, 619-625.
149. Kawana, Y.; Kawana, K.; Yoshikawa, H.; Taketani, Y.; Yoshiike, K.; Kanda, T. Human papillomavirus type 16 minor capsid protein l2 n-terminal region containing a common neutralization epitopebinds to the cell surface and enters the cytoplasm. J. Virol. 2001, 75, 2331-2336.
150. Woodham, A.W.; Da Silva, D.M.; Skeate, J.G.; Raff, A.B.; Ambroso, M.R.; Brand, H.E.; Isas, J.M.; Langen, R.; Kast, W.M. The s100a10 subunit ofthe annexin a2 heterotetramer facilitates l2-mediated human papillomavirus infection. PLoS One 2012, 7, e43519.
151. Yang, R.C.; Day, P.M.; Yutzy, W.H.; Lin, K.Y.; Hung, C.F.; Roden, R.B.S. Cell surface-binding motifs of l2 that facilitate papillomavirus infection. J. Virol. 2003, 77, 3531-3541.
152. Holmgren, S.C.; Patterson, N.A.; Ozbun, M.A.; Lambert, P.F. The minorcapsid protein l2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 2005, 79, 3938-3948.
153. Roden, R.B.S.; Day, P.M.; Bronzo, B.K.; Yutzy, W.H.; Yang, Y.Q.; Lowy, D.R.; Schiller, J.T. Positively charged termini of the l2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 2001, 75, 10493-10497.
154. Kamper, N.; Day, P.M.; Nowak, T.; Selinka, H.C.; Florin, L.; Bolscher, J.; Hilbig, L.; Schiller, J.T.; Sapp, M. A membrane-destabilizing peptide incapsid protein l2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 2006, 80, 759-768.
155. Campos, S.K.; Ozbun, M.A. Two highly conserved cysteine residues in hpv16 l2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One 2009, 4, e4463.
156. Gambhira, R.; Jagu, S.; Karanam, B.; Day, P.M.; Roden, R. Role of l2 cysteines in papillomavirus infection and neutralization. Virol. J. 2009, 6, 176.
157. Bronnimann, M.P.; Chapman, J.A.; Park, C.K.; Campos, S.K. A transmembrane domain and gxxxg motifs within l2 are essential for papillomavirus infection. J. Virol. 2013, 87, 464-473.
158. Ishii, Y.; Tanaka, K.; Kondo, K.; Takeuchi, T.; Mori, S.; Kanda, T. Inhibition of nuclear entry of hpv16 pseudovirus-packaged dna by an anti-hpv16 l2neutralizing antibody. Virology 2010, 406, 181-188.
159. Marusic, M.B.; Ozbun, M.A.; Campos, S.K.; Myers, M.P.; Banks, L. Human papillomavirus l2 facilitates viral escape from lateendosomes via sorting nexin 17. Traffic 2012, 13, 455-467.
160. Bergant, M.; Banks, L. Snx17 facilitates infection with diverse papillomavirus types. J. Virol. 2013, 87, 1270-1273.
161. Laniosz, V.; Nguyen, K.C.; Meneses, P.I. Bovine papillomavirus type 1 infection is mediated by snare syntaxin 18. J. Virol. 2007, 81, 7435-7448.
162. Ishii, Y.; Nakahara, T.; Kataoka, M.; Kusumoto-Matsuo, R.; Mori, S.; Takeuchi, T.; Kukimoto, I. Identification of trappc8 as a host factor required for human papillomavirus cell entry. PLoS One 2013, 8, e80297.
163. Liu, W.J.; Qi, Y.M.; Zhao, K.N.; Liu, Y.H.; Liu, X.S.; Frazer, I.H. Association of bovine papillomavirus type 1 with microtubules. Virology 2001, 282, 237-244.
164. Zhou, J.; Gissmann, L.; Zentgraf, H.; Muller, H.; Picken, M.; Muller, M. Early phase in the infection of cultured-cells with papillomavirus virions. Virology 1995, 214, 167-176.
165. Florin, L.; Becker, K.A.; Lambert, C.; Nowak, T.; Sapp, C.; Strand, D.; Streeck, R.E.; Sapp, M. Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J. Virol. 2006, 80, 6691-6696.
166. Schneider, M.A.; Spoden, G.A.; Florin, L.; Lambert, C. Identification of the dynein light chains required for human papillomavirus infection. Cell. Microbiol. 2011, 13, 32-46.
167. Day, P.M.; Baker, C.C.; Lowy, D.R.; Schiller, J.T. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (pml) expression. Proc. Natl. Acad. Sci. USA 2004, 101, 14252-14257.
168. Bienkowska-Haba, M.; Williams, C.; Kim, S.M.; Garcea, R.L.; Sapp, M. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein l1 from the l2/dna complex following virus entry. J. Virol. 2012, 86, 9875-9887.
169. Lee, J.E.; Lim, H.J. Ldp12, a novel cell-permeablepeptide derived from l1 capsid protein of the human papillomavirus. Mol. Biol. Rep. 2012, 39, 1079-1086.
170. Liddington, R.C.; Yan, Y.; Moulai, J.; Sahli, R.; Benjamin, T.L.; Harrison, S.C. Structure of simian virus-40 at 3.8-a resolution. Nature 1991, 354, 278-284.
171. Barouch, D.H.; Harrison, S.C. Interactions among the major and minor coat proteins of polyomavirus. J. Virol. 1994, 68, 3982-3989.
172. Chen, X.J.S.; Stehle, T.; Harrison, S.C. Interaction of polyomavirus internal protein vp2 with the major capsid protein vp1 and implications for participation of vp2 in viral entry. EMBO J. 1998, 17, 3233-3240.
173. Streuli, C.H.; Griffin, B.E. Myristic acid is coupled to a structural protein of polyoma-virus and sv40. Nature 1987, 326, 619-622.
174. Gross, L. A filterable agent, recovered fromak leukemic extracts, causing salivary gland carcinomas in c3h mice. Proc. Soc. Exp. Biol. Med. 1953, 83, 414-421.
175. Dalianis, T.; Hirsch, H.H. Human polyomaviruses in disease and cancer. Virology 2013, 437, 63-72.
176. Feng, H.C.; Shuda, M.; Chang, Y.; Moore, P.S. Clonal integration of a polyomavirus in human merkel cell carcinoma. Science 2008, 319, 1096-1100.
177. Tsai, B.; Gilbert, J.M.; Stehle, T.; Lencer, W.; Benjamin, T.L.; Rapoport, T.A. Gangliosides are receptors for murine polyoma virus and sv40. EMBO J. 2003, 22, 4346-4355.
178. Qian, M.D.; Tsai, B. Lipids and proteins act in opposing manners to regulate polyomavirus infection. J. Virol. 2010, 84, 9840-9852.
179. Low, J.A.; Magnuson, B.; Tsai, B.; Imperiale, M.J. Identification of gangliosides gd1b and gt1b as receptors for bk virus. J. Virol. 2006, 80, 1361-1366.
180. Ewers, H.; Romer, W.; Smith, A.E.; Bacia, K.; Dmitrieff, S.; Chai, W.G.; Mancini, R.; Kartenbeck, J.; Chambon, V.; Berland, L.;et al. Gm1 structure determines sv40-induced membrane invagination and infection. Nat. Cell Biol. 2010, 12, U11-U36.
181. Cavaldesi, M.; Caruso, M.; Sthandier, O.; Amati, P.; Garcia, M.I. Conformational changes of murine polyomavirus capsid proteins induced by sialicacid binding. J. Biol. Chem. 2004, 279, 41573-41579.
182. Qian, M.D.; Cai, D.W.; Verhey, K.J.; Tsai, B. A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Pathog. 2009, 5, e1000465.
183. Pho, M.T.; Ashok, A.; Atwood, W.J. Jc virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000, 74, 2288-2292.
184. Anderson, H.A.; Chen, Y.Z.; Norkin, L.C. Bound simian virus 40 translocates to caveolinenriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 1996, 7, 1825-1834.
185. Richterova, Z.; Liebl, D.; Horak, M.; Palkova, Z.; Stokrova, J.; Hozak, P.; Korb, J.; Forstova, J. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial vp1 pseudocapsids toward cell nuclei. J. Virol. 2001, 75, 10880-10891.
186. Eash, S.; Querbes, W.; Atwood, W.J. Infection of vero cells by bk virus is dependent on caveolae. J. Virol. 2004, 78, 11583-11590.
187. Gilbert, J.M.; Goldberg, I.G.; Benjamin, T.L. Cell penetration and trafficking of polyomavirus. J. Virol. 2003, 77, 2615-2622.
188. Ashok, A.; Atwood, W.J. Contrasting roles of endosomal ph and the cytoskeleton in infection of human glial cells by jc virus and simian virus 40. J. Virol. 2003, 77, 1347-1356.
189. Moriyama, T.; Sorokin, A. Intracellular trafficking pathway of bk virus in human renal proximal tubular epithelial cells. Virology 2008, 371, 336-349.
190. Pelkmans, L.; Kartenbeck, J.; Helenius, A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the er. Nat. Cell Biol. 2001, 3, 473-483.
191. Damm, E.M.; Pelkmans, L.; Kartenbeck, J.; Mezzacasa, A.; Kurzckalia, T.; Helenius, A. Clathrin-and caveolin-1-independent endocytosis: Entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 2005, 168, 477-488.
192. Liebl, D.; Difato, F.; Hornikova, L.; Mannova, P.; Strokrova, J.; Forstova, J. Mouse polyomavirus enters early endosomes, requires their acidic ph for productive infection, and meets transferrin cargo in rab11-positive endosomes. J. Virol. 2006, 80, 4610-4622.
193. Mannova, P.; Forstova, J. Mouse polyomavirus utilizes recycling endosomes for a traffic pathway independent of copi vesicle transport. J. Virol. 2003, 77, 1672-1681.
194. Gilbert, J.; Benjamin, T. Uptake pathway of polyomavirus via ganglioside gd1a. J. Virol. 2004, 78, 12259-12267.
195. Richards, A.A.; Stang, E.; Pepperkok, R.; Parton, R.G. Inhibitors of cop-mediated transport and cholera toxin action inhibit simian virus 40 infection. Mol. Biol. Cell 2002, 13, 1750-1764.
196. Norkin, L.C.; Anderson, H.A.; Wolfrom, S.A.; Oppenheim, A. Caveolar endocytosis of simian virus 40 is followed by brefeldin a-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 2002, 76, 5156-5166.
197. Norkin, L.C.; Kuksin, D. The caveolae-mediatedsv40 entry pathway bypasses the golgi complex en route to the endoplasmic reticulum. Virol. J. 2005, 2, 38.
198. Zila, V.; Difato, F.; Klimova, L.; Huerfano, S.; Forstova, J. Involvement of microtubular network and its motors in productive endocytictrafficking of mouse polyomavirus. PLoS One 2014, 9, e96922.
199. Walczak, C.P.; Tsai, B. A pdi family network acts distinctly and coordinately with erp29 to facilitate polyomavirus infection. J. Virol. 2011, 85, 2386-2396.
200. Schelhaas, M.; Malmstrom, J.; Pelkmans, L.; Haugstetter, J.; Ellgaard, L.; Grunewald, K.; Helenius, A. Simian virus 40 depends on er protein folding and quality control factors for entry into host cells. Cell 2007, 131, 516-529.
201. Gilbert, J.; Ou, W.; Silver, J.; Benjamin, T. Downregulation of protein disulfide isomerase inhibits infection by the mouse polyomavirus. J. Virol. 2006, 80, 10868-10870.
202. Geiger, R.; Andritschke, D.; Friebe, S.; Herzog, F.; Luisoni, S.; Heger, T.; Helenius, A. Bap31 and bip are essential for dislocation of sv40 from the endoplasmic reticulum to the cytosol. Nat. Cell Biol. 2011, 13, U1305-U1360.
203. Goodwin, E.C.; Lipovsky, A.; Inoue, T.; Magaldi, T.G.; Edwards, A.P.B.; Van Goor, K.E.Y.; Paton, A.W.; Paton, J.C.; Atwood, W.J.; Tsai, B.;et al. Bip and multiple dnaj molecular chaperones in the endoplasmic reticulum are required for efficient simian virus 40 infection. Mbio 2011, 2, e00101-11.
204. Lilley, B.N.; Gilbert, J.M.; Ploegh, H.L.; Benjamin, T.L. Murine polyomavirus requires the endoplasmic reticulum protein derlin-2 to initiate infection. J. Virol. 2006, 80, 8739-8744.
205. Bennett, S.M.; Jiang, M.; Imperiale, M.J. Role of cell-type-specific endoplasmic reticulumassociated degradation in polyomavirus trafficking. J. Virol. 2013, 87, 8843-8852.
206. Chen, P.L.; Wang, M.L.; Ou, W.C.; Lii, C.K.; Chen, L.S.; Chang, D.C. Disulfide bonds stabilize jc virus capsid-like structure by protecting calcium ions from chelation. FEBS Lett. 2001, 500, 109-113.
207. Stehle, T.; Harrison, S.C. High-resolution structure of a polyomavirus vp1-oligosaccharide complex: Implications for assembly and receptor binding. EMBO J. 1997, 16, 5139-5148.
208. Gharakhanian, E.; Fasching, C.L.; Orlando, S.J.; Perez, A.R. Cys(9), cys(104) and cys(207) of simian virus 40 vp1 are essential for infectious virion formation in cv-1 celss. J. Gen. Virol. 2001, 82, 1935-1939.
209. Salunke, D.M.; Caspar, D.L.D.; Garcea, R.L. Self-assembly of purified polyomavirus capsid protein-vp1. Cell 1986, 46, 895-904.
210. Daniels, R.; Rusan, N.M.; Wadsworth, P.; Hebert, D.N. Sv40vp2 and vp3 insertion into er membranes is controlled by the capsid protein vp1: Implications for dna translocation out of the er. Mol. Cell 2006, 24, 955-966.
211. Gharakhanian, E.; Munoz, L.; Mayorca, L. The simian virus 40 minor structural protein vp3, but not vp2, is essential for infectious virion formation. J. Gen. Virol. 2003, 84, 2111-2116.
212. Enomoto, T.; Kukimoto, I.; Kawano, M.A.; Yamaguchi, Y.; Berk, A.J.; Handa, H. In vitro reconstitution of sv40 particles that are composed of vp1/2/3 capsid proteins and nucleosomal dna and direct efficient gene transfer. Virology 2011, 420, 1-9.
213. Nakanishi, A.; Itoh, N.; Li, P.P.; Handa, H.; Liddington, R.C.; Kasamatsu, H. Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. J. Virol. 2007, 81, 3778-3785.
214. Stehle, T.; Harrison, S.C. Crystal structures ofmurine polyomavirus in complex with straightchain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4, 183-194.
215. Neu, U.; Woellner, K.; Gauglitz, G.; Stehle, T. Structural basis of gm1 ganglioside recognition by simian virus 40. Proc. Natl. Acad. Sci. USA 2008, 105, 5219-5224.
216. Inoue, T.; Tsai, B. A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathog. 2011, 7, e1002037.
217. Forstova, J.; Krauzewicz, N.; Wallace, S.; Street, A.J.; Dilworth, S.M.; Beard, S.; Griffin, B.E. Cooperation of structural proteins during late events in the life-cycle of polyomavirus. J. Virol. 1993, 67, 1405-1413.
218. Delos, S.E.; Montross, L.; Moreland, R.B.; Garcea, R.L. Expression of the polyomavirus vp2 and vp3 proteins in insect cells-Coexpression with the major capsid protein vp1 alters vp2/vp3 subcellular-localization. Virology 1993, 194, 393-398.
219. Huerfano, S.; Zila, V.; Boura, E.; Spanielova, H.; Stokrova, J.; Forstova, J. Minor capsid proteins of mouse polyomavirus are inducers of apoptosis when produced individually but are only moderate contributors to cell death during the late phase of viral infection. FEBS J. 2010, 277, 1270-1283.
220. Giorda, K.M.; Raghava, S.; Zhang, M.W.; Hebert, D.N. The viroporin activity of the minor structural proteins vp2 and vp3 is required for sv40 propagation. J. Biol. Chem. 2013, 288, 2510-2520.
221. Raghava, S.; Giorda, K.M.; Romano, F.B.; Heuck, A.P.; Hebert, D.N. Sv40 late protein vp4 forms toroidal pores to disruptmembranes for viral release. Biochemistry 2013, 52, 3939-3948.
222. Daniels, R.; Sadowicz, D.; Hebert, D.N. A very late viral protein triggers the lytic release of sv40. PLoS Pathog. 2007, 3, 928-938.
223. Fiser, R.; Forstova, J. Department of Genetics and Microbiology, Charles University, Prague, Czech Republic. Unpublished work, 2008.
224. Cai, X.Y.; Chang, D.C.; Rottinghaus, S.; Consigli, R.A. Expression and purification of recombinant polyomavirus vp2 protein and its interactions with polyomavirus proteins. J. Virol. 1994, 68, 7609-7613.
225. Hornikova, L.; Forstova, J. Department of Genetics and Microbiology, Charles University, Prague, Czech Republic. Unpublished work, 2012.
226. Schowalter, R.M.; Buck, C.B. The merkelcell polyomavirus minor capsid protein. PLoS Pathog. 2013, 9, e1003558.
227. Magnuson, B.; Rainey, E.K.; Benjamin, T.; Baryshev, M.; Mkrtchian, S.; Tsai, B. Erp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell 2005, 20, 289-300.
228. Attar, N.; Cullen, P.J. The retromer complex. Adv. Enzym. Regul. 2010, 50, 216-236.
229. Walczak, C.P.; Ravindran, M.S.; Inoue, T.; Tsai, B. A cytosolic chaperone complexes with dynamic membrane j-proteins and mobilizes a nonenveloped virus out of the endoplasmic reticulum. PLoS Pathog 2014, 10, e1004007.
230. Nakanishi, A.; Shum, D.; Morioka, H.; Otsuka, E.; Kasamatsu, H. Interaction of the vp3 nuclear localization signal with the importin alpha-2/beta heterodimer directs nuclear entry of infecting simian virus 40. J. Virol. 2002, 76, 9368-9377.
231. Nakanishi, A.; Li, P.P.; Qu, Q.M.; Jafri, Q.H.; Kasamatsu, H. Molecular dissection of nuclear entry-competent sv40 during infection. Virus Res. 2007, 124, 226-230.
232. Kuksin, D.; Norkin, L.C. Disassociation of the sv40 genome from capsid proteins prior to nuclear entry. Virol. J. 2012, 9, 158.
233. Hummeler, K.; Tomassin, N.; Sokol, F. Morphological aspects of uptake ofsimian-virus-40 by permissive cells. J. Virol. 1970, 6, 87-93.
234. Mackay, R.L.; Consigli, R.A. Early events in polyoma-virus infection-attachment, penetration, and nuclear entry. J. Virol. 1976, 19, 620-636.
235. Butin-Israeli, V.; Ben-nun-Shaul, O.; Kopatz, I.; Adam, S.A.; Shimi, T.; Goldman, R.D.; Oppenheim, A. Simian virus 40 induces lamin a/c fluctuations and nuclear envelope deformation during cell entry. Nucleus-Austin 2011, 2, 320-330.